Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?

Area of Science:

• Endothelial Biology
• Diabetic Complications
• Vascular Medicine

Background:

• Diabetes mellitus is characterized by hyperglycemia, leading to vascular abnormalities.
• Endothelial progenitor cells (EPCs) play a role in vascular health, but their function in diabetic microvascular disease is debated.
• Current therapies for diabetic retinopathy and nephropathy, such as anti-VEGF treatments, highlight uncertainties regarding EPC involvement.

Purpose of the Study:

• To elucidate the impact of hyperglycemia on EPCs' metabolic and epigenetic profiles.
• To examine the mechanisms of abnormal angiogenesis in diabetic eyes and kidneys.
• To clarify the role of EPCs in diabetic microvascular complications and explore therapeutic strategies.

Main Methods:

• Review of existing literature on hyperglycemia's effects on EPCs.
• Analysis of molecular mechanisms underlying diabetic retinopathy and nephropathy, including VEGF and nitric oxide interactions, and angiopoietin signaling.
• Evaluation of current EPC-based therapeutic approaches and identification of future research directions.

Main Results:

• Hyperglycemia induces detrimental metabolic and epigenetic alterations in EPCs, reducing their number and impairing function.
• Shared mechanisms of abnormal angiogenesis in diabetic eyes and kidneys involve 'VEGF uncoupling with nitric oxide' and 'competitive angiopoietin 1/angiopoietin 2' signaling.
• The precise role of EPCs in diabetic microvascular complications requires further elucidation.

Conclusions:

• Understanding the complex role of EPCs in diabetic microvascular disease is crucial for developing effective therapies.
• Targeting hyperglycemia-induced changes in EPCs presents a promising therapeutic strategy for diabetic retinopathy and nephropathy.
• Further research into EPC-associated options is warranted to uncover novel treatment modalities.